APHG, now part owned by the Super Fund, reports profit up 17%.
Pathology group APHG has posted a bumper profit for the year to December, boosted by its major role in providing Covid-19 tests.
Net profit for the year was $40.4 million from revenue of $307.7m, up from $34.4m and $264.3m respectively in the year to June 2019 before a change of balance
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearlyNZ$399.00 / yearly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Subscription
NZ$29.95 / monthly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Yearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Tim Hunter
Thu, 06 May 2021
Contact the Writer: thunter@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
